You are here

Merck

Merck looks to cardiovascular pipeline for $10B+ peak sales—and diversification from Keytruda

Fierce Biotech

Tue, 04/5/22 - 11:36 pm

cardiovascular disease

Ukraine war, China's COVID lockdown and more could weigh on J&J's early-year performance—and it may not be alone: analysts

Fierce Pharma

Tue, 04/5/22 - 11:53 am

How did Merck record an 11% tax rate last year? The Senate finance chairman would like to know

Fierce Pharma

Tue, 04/5/22 - 11:07 am

New Studies Support Benefit of Merck's Molnupiravir

BioSpace

Mon, 04/4/22 - 11:13 pm

Ridgeback Biotherapeutics

clinical trials

Merck, nearing completion of $1B Gardasil manufacturing push, eyes 2023 to double production⁠—again

Fierce Pharma

Mon, 04/4/22 - 10:22 am

drug manufacturing

2 Drugmakers Set for Explosive Revenue This Decade

Motley Fool

Mon, 04/4/22 - 10:16 am

Bristol Myers Squibb

Merck, amid pneumococcal vaccine race with Pfizer, suffers FDA delay for key pediatric use

Fierce Pharma

Fri, 04/1/22 - 10:45 am

pneumococcal disease

Workforce Cuts Abound at Zealand Pharma, Merck and Orchard

BioSpace

Thu, 03/31/22 - 10:43 am

Orchard Therapeutics

Merck cuts 170 jobs at Acceleron right on heels of $11.5B buyout

Fierce Pharma

Wed, 03/30/22 - 11:05 am

Merck, Roche and J&J among pharma players weighing Russian operations amid humanitarian tightrope walk

Fierce Pharma

Tue, 03/29/22 - 11:43 pm

Bristol Myers Squibb, Merck hit setback in bid to expand Reblozyl's anemia nod

Fierce Pharma

Fri, 03/25/22 - 10:33 am

Bristol Myers Squibb

beta thalassemia

After Supreme Court win, Merck prevails against 500 Fosamax cases: report

Fierce Pharma

Thu, 03/24/22 - 08:34 pm

Merck telegraphs closure of Pennsylvania antibiotics plant that employs 300

Fierce Pharma

Thu, 03/24/22 - 11:27 am

drug manufacturing

FDA approves Merck’s anti-PD-1 therapy for endometrial carcinoma patients

Pharmaceutical Business Review

Tue, 03/22/22 - 10:41 am

endometrial cancer

Merck fights back against Roche in adjuvant lung cancer therapy

Pharmaforum

Fri, 03/18/22 - 10:54 am

non-small cell lung cancer

clinical trials

Merck Announces Ups and Downs Involving Blockbuster Keytruda

BioSpace

Tue, 03/15/22 - 11:39 pm

Merck antiviral used more than expected, data shows

Beckers Hospital Review

Mon, 03/14/22 - 11:35 pm

FDA clears AstraZeneca, Merck drug to treat some genetic breast cancers early

BioPharma Dive

Mon, 03/14/22 - 10:26 am

genetic breast cancer

Death in Alpine's Keytruda combo trial triggers clinical hold, raises specter of earlier tragedy

Fierce Biotech

Mon, 03/7/22 - 11:01 pm

Alpine Immune Sciences

clinical trials

Pages